Hypha Labs, Inc. Releases Investor Presentation
Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, has released its first Investor Presentation since commencing trading on the OTCQB. The dynamic presentation, available at www.HyphaLabs.com/deck, outlines the company's plan to empower home and commercial production of functional mushroom ingredients.
CEO Stone Douglass stated that Hypha Labs has been methodically pursuing its path to distribute and sell an award-winning device for producing high-quality functional mushroom ingredients. The company has enhanced its corporate presence by adding a respected Investor Relations agency and uplisting to the OTCQB. Douglass expressed confidence in the company's readiness for the anticipated interest accompanying the roll-out of their first bio-reactor sales.
Hypha Labs, Inc. (OTCQB:FUNI), un pioniere nelle scienze dei funghi funzionali, ha rilasciato la sua prima Presentazione per gli Investitori da quando ha iniziato a operare sull'OTCQB. La presentazione dinamica, disponibile su www.HyphaLabs.com/deck, delinea il piano dell'azienda di favorire la produzione commerciale e domestica di ingredienti a base di funghi funzionali.
Il CEO Stone Douglass ha dichiarato che Hypha Labs ha seguito metodicamente la sua strada per distribuire e vendere un dispositivo premiato per la produzione di ingredienti a base di funghi funzionali di alta qualità. L'azienda ha potenziato la sua presenza aziendale aggiungendo un'agenzia di Relazioni con gli Investitori rispettata e trasferendosi all'OTCQB. Douglass ha espresso fiducia nella prontezza dell'azienda per l'interesse previsto in concomitanza con il lancio delle loro prime vendite di bio-reattori.
Hypha Labs, Inc. (OTCQB:FUNI), un pionero en las ciencias de los hongos funcionales, ha lanzado su primera Presentación para Inversores desde que comenzó a cotizar en el OTCQB. La presentación dinámica, disponible en www.HyphaLabs.com/deck, describe el plan de la empresa para fomentar la producción de ingredientes de hongos funcionales tanto en casa como en el ámbito comercial.
El CEO Stone Douglass declaró que Hypha Labs ha estado persiguiendo metódicamente su camino para distribuir y vender un dispositivo galardonado para producir ingredientes de hongos funcionales de alta calidad. La empresa ha mejorado su presencia corporativa al añadir una agencia de relaciones con inversores respetada y subir a OTCQB. Douglass expresó confianza en la preparación de la empresa para el interés anticipado que se espera con el lanzamiento de sus primeras ventas de bio-reactores.
Hypha Labs, Inc. (OTCQB:FUNI), 기능성 버섯 과학의 선구자로서 OTCQB에서 거래를 시작한 이후 첫 번째 투자자 발표를 출시했습니다. www.HyphaLabs.com/deck에서 확인할 수 있는 이 역동적인 프레젠테이션은 회사의 기능성 버섯 원료의 가정 및 상업 생산을 촉진할 계획을 설명합니다.
CEO 스톤 더글라스는 Hypha Labs가 고품질 기능성 버섯 원료를 생산하기 위한 수상 경력에 빛나는 장치를 배급 및 판매하기 위한 path를 체계적으로 추구해왔다고 언급했습니다. 이 회사는 존경받는 투자자 관계 대행사를 추가하고 OTCQB로 상장하여 기업 존재감을 강화했습니다. 더글라스는 생물 반응기 판매의 첫 출시와 함께 예상되는 관심에 대한 회사의 준비 상태에 대한 신뢰를 표명했습니다.
Hypha Labs, Inc. (OTCQB:FUNI), un pionnier dans le domaine des sciences des champignons fonctionnels, a publié sa première Présentation pour les Investisseurs depuis le début de ses échanges sur l'OTCQB. La présentation dynamique, disponible sur www.HyphaLabs.com/deck, décrit le plan de l'entreprise pour favoriser la production d'ingrédients de champignons fonctionnels tant à domicile qu'à des fins commerciales.
Le CEO Stone Douglass a déclaré que Hypha Labs a suivi méthodiquement son chemin pour distribuer et vendre un dispositif primé pour produire des ingrédients de champignons fonctionnels de haute qualité. L'entreprise a renforcé sa présence sur le marché en ajoutant une agence de relations investisseurs respectée et en s'inscrivant sur l'OTCQB. Douglass a exprimé sa confiance dans la préparation de l'entreprise face à l'intérêt anticipé lié au lancement de leurs premières ventes de bio-réacteurs.
Hypha Labs, Inc. (OTCQB:FUNI), ein Pionier in den funktionalen Pilzwissenschaften, hat seine erste Investorenpräsentation seit Aufnahme des Handels am OTCQB veröffentlicht. Die dynamische Präsentation, verfügbar unter www.HyphaLabs.com/deck, skizziert den Plan des Unternehmens, die Produktion funktionaler Pilzbestandteile sowohl im Heim- als auch im Gewerbebereich zu fördern.
CEO Stone Douglass erklärte, dass Hypha Labs systematisch seinen Weg verfolgt hat, um ein ausgezeichnetes Gerät zur Produktion hochwertiger funktionaler Pilzbestandteile zu vertreiben und zu verkaufen. Das Unternehmen hat seine Unternehmenspräsenz durch die Hinzunahme einer angesehenen Investor-Relations-Agentur und die Listung am OTCQB verbessert. Douglass äußerte Vertrauen in die Bereitschaft des Unternehmens für das erwartete Interesse, das mit der Einführung ihrer ersten Bio-Reaktor-Verkäufe verbunden ist.
- Uplisting to OTCQB, potentially increasing visibility and liquidity
- Release of first Investor Presentation, improving transparency
- Preparation for commercial launch of award-winning functional mushroom production device
- Addition of a respected Investor Relations agency
- None.
Dynamic Deck Outlines Company's Plan to Empower Home and Commercial Production of Functional Mushroom Ingredients
LAS VEGAS, NV / ACCESSWIRE / September 23, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has released its first Investor Presentation since it commenced trading on the OTCQB, a premier market operated by OTC Markets Group, Inc.
The Investor Presentation is available at www.HyphaLabs.com/deck and is intended to be dynamic, meaning the Company intends to update the deck at the current link as it continues to execute its business model in the vast Functional Mushroom industry.
"Over the past few months Hypha Labs has methodically pursued our path to the distribution and sale of an Award-winning device for home and commercial production of the finest functional mushroom ingredients," stated Stone Douglass, CEO, Hypha Labs. "And while our team prepares for a commercial launch of our device in the months ahead, we've diligently enhanced our corporate presence by adding a highly respected Investor Relations agency, uplisting to the OTCQB and now, an Investor Presentation that provides full transparency and clarity of our mission."
"We believe we are more than ready to receive the interest and inquiry that we anticipate will accompany the Company's roll-out of our first bio-reactor sales," added Douglass.
About Hypha Labs, Inc.
The company has developed revolutionary cutting-edge technology focused on new methods of producing the active ingredients found in functional mushrooms such as psilocybin using its patent-pending bioreactor design. The Company has positioned itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in the psilocybin space which is quickly manifesting into a similar pattern that was seen in the Cannabis Industry both from a medical and recreational usage with several states and cities have now decriminalized it use. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity Media Inc.
(888) 216-3595
team@integritymedia.com
SOURCE: Hypha Labs, Inc.
View the original press release on accesswire.com
FAQ
What is Hypha Labs' (FUNI) main product focus?
When did Hypha Labs (FUNI) start trading on the OTCQB?
Where can investors find Hypha Labs' (FUNI) Investor Presentation?
What recent corporate developments has Hypha Labs (FUNI) announced?
